Health Monitoring Process has many similarities Clinical Trials.
When is consent required more than once? For example: When a new PaaS AI supplier accesses the data? When during monitoring something new/different is monitored in the patient such as moods using a mood-tracking App? ( See https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676196/ )
How can we design the Hyperledger Consent API to be universally used in all cases? Standardization?
API Structure is to be defined
Clinical trials use AI monitoring engine linked to a drug treatment plan?
What is the particular Treatment in Diabetes?
Which Framework is the best in Hyperledger? Fabric or Sawtooth? Criteria for the selection?
The data flow between Data and Process Layer
Payer Subgroup (Raveesh Dewan, Lead)
Ankit provided an update on the work being done through the Payer Subgroup, including:
A successful Meetup event that happened on July 18, with 18-20 persons attending
Steven updated the group on his plans to kick off the HIS, happening on SEP 04
HC-SIG Ad Hoc Team Updates
Wiki Redesign Team (Raveesh Dewan, Lead)
Work continues on our SIG site design
Discussion: are you a Confluence expert... interested in joining this team?
Academic Research Team (Logan Wilding, Wendy Charles, Nisarg Amin, and Adrian Berg, Lead)
HC-SIG Use Case Development Team (Wendy Charles, Lead)
Wendy provided an update on her team's work, planning to attend a meeting with community leadership to talk through the availability templates to be used for work related to use case development